True Blue On A Mission
NSWRL True Blue, Rugby League legend and cancer survivor Paul Langmack will tackle the 2016 City2Surf to raise money for Chris O’Brien Lifehouse.
Chris O’Brien Lifehouse strives to deliver the best cancer care, as a not-for-profit, independent comprehensive cancer centre specialising in state of-the-art advanced cancer care, and rare and complex cases – and they recently cared for Langmack who is recovering from cancer in his lymph nodes.
Langmack, a four-time NSW Origin representative and a three-time premiership winner, is keen to support the organisation that supported him during his toughest battle.
“Everyone knows someone touched by cancer – joining me for the 2016 City2Surf or donating money for the cause is a great way to show your support,” Langmack said.
“Walk the course with me, I’ll tell a few yarns, we’ll have a great time and celebrate life – during the race and after it too. It’s all for a great cause, Chris O’Brien Lifehouse.”
NSWRL CEO David Trodden said the organisation was proud of Langmack.
“The NSWRL is proud of Paul for contributing to such a great organisation – and for turning a difficult time in his life into a positive,” Trodden said.
“We’re incredibly supportive of his endeavours and encourage the Rugby League public to get behind Paul and Chris O’Brien Lifehouse.”
Using the latest technology in a modern, purpose-built cancer hospital, Chris O’Brien Lifehouse’s highly experienced clinicians treat almost 50,000 public and private patients every year – concentrating all their efforts, learning, research and expertise into cancer care alone.
Specialists work in multidisciplinary teams of surgeons, medical oncologists, radiation oncologists, psychologists and researchers to provide peer-reviewed, tailored, individualised treatment to patients.
Lifehouse is also New South Wales’ and one of Australia’s biggest cancer clinical trials centres, with more than 140 clinical trials and research projects giving our patients access to the world’s newest cancer breakthroughs.
Research and trials are carried out by the same clinicians who treat patients, shortening the path between discovery and more effective new treatments for patients. International research has confirmed this approach, at comprehensive cancer centres in the United States and Europe, results in outcomes that are five to 15 per cent better for patients after five years.
To support Paul Langmack and Chris O’Brien Lifehouse in the 2016 City2Surf click here to donate – or register for the City2Surf and proceed to the fundraising page to nominate Lifehouse as your chosen charity.